InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: Grip it and Sip It post# 16173

Tuesday, 07/25/2017 11:21:59 AM

Tuesday, July 25, 2017 11:21:59 AM

Post# of 233151
Grip, I appreciate the respect and your demeanor on this board.

Management is concerned with one thing only right now. Complete enrollment in both Combo and Mono and let the empirical data decide Pro-140's fate. This Combo Trial has been a bitch to enroll as these patients are very sick and need a lot of hand holding. Mono is a completely different animal - enrollment is a slam dunk by years end at latest.

They are very confident as to the strength of the data in both Combo and Mono - why wouldn't they be? Unless you listen to Pears which I give zero credibility.

They know the holy grail is riding on Mono. It's pedal to the medal to enroll when Mono when Combo enrollment is completed.

They are not concerned with raising the $'s needed to complete both trials. There is plenty of interest as this investment continues to be de-risked.

BTD will be viable once Combo PE and safety data is made available to FDA. The pathway to approval will then be clear.

The trials will soon be on a time clock because once enrollment is complete the clock starts. That defines dates on when data will be available.

Tony C and Dr. Burger are well seasoned with the landscape that we are traversing. Speaking of Dr. Burger he thinks we have an ace in the hole with GVHD. We could see a deal in this space this year.

They are going to R/S if we don't get an organic uplist this year. They feel we have to get off the OTC and open the gates to institutions. They feel that there is enough good news to support an R/S if that is the case.

They would not take $5 per share at this moment in time. Tony C's goal is to maximize shareholder value and sell this company within the next 12 months.

What the SP does day to day is meaningless until Combo PE data is released. That is the defining moment that will start the momentum.

I believe the data is going to be strong in both trials and CYDY will be purchased no later than this time next year in the $6-$8 range.

I've waited for this point in time for Four years. I'm ready for the last chapter. I'm not a day trader I'm an investor that stays close to the story. I like this board because I like to know what people are thinking. My main observation is speculation is just that.

Either you believe in the science and Tony C' competence or you don't. I do.

All IMHO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News